HWAM
Hennion & Walsh Asset Management Portfolio holdings
AUM
$2.48B
1-Year Return
14.59%
This Quarter Return
+8.4%
1 Year Return
+14.59%
3 Year Return
+61.58%
5 Year Return
–
10 Year Return
–
AUM
$2.48B
AUM Growth
+$226M
(+10%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
4.19%
Top 10 Holdings %
Top 10 Hldgs %
18.66%
Holding
956
New
89
Increased
439
Reduced
377
Closed
40
Top Buys
Top Sells
| 1 |
Global X US Preferred ETF
PFFD
|
$29.4M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
$15.3M |
| 3 |
Insmed
INSM
|
$2.72M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$2.44M |
| 5 |
Avidity Biosciences
RNA
|
$1.84M |
Sector Composition
| 1 | Technology | 12.6% |
| 2 | Financials | 10.31% |
| 3 | Healthcare | 9.29% |
| 4 | Industrials | 6.6% |
| 5 | Consumer Discretionary | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
CommScope
COMM
$3.55B
| $171K | 0.01% |
+20,700
| New | +$171K |
|
902
NOV
NOV
$4.95B
| $143K | 0.01% |
11,511
-134
| -1% | -$1.67K |
|
903
DHI Group
DHX
$143M
| $135K | 0.01% |
45,563
-5,790
| -11% | -$17.2K |
|
904
PagSeguro Digital
PAGS
$2.8B
| $131K | 0.01% |
+13,597
| New | +$131K |
|
905
Ironwood Pharmaceuticals
IRWD
$188M
| $124K | 0.01% |
172,579
-7,973
| -4% | -$5.72K |
|
906
Sally Beauty Holdings
SBH
$1.44B
| $122K | ﹤0.01% |
+13,125
| New | +$122K |
|
907
Pliant Therapeutics
PLRX
$114M
| $116K | ﹤0.01% |
99,819
-4,611
| -4% | -$5.35K |
|
908
KRONOS Worldwide
KRO
$713M
| $110K | ﹤0.01% |
+17,676
| New | +$110K |
|
909
Superior Group of Companies
SGC
$195M
| $109K | ﹤0.01% |
10,544
-152
| -1% | -$1.57K |
|
910
Repay Holdings
RPAY
$506M
| $94.9K | ﹤0.01% |
19,681
-334
| -2% | -$1.61K |
|
911
1-800-Flowers.com
FLWS
$324M
| $92.2K | ﹤0.01% |
18,737
-4
| -0% | -$20 |
|
912
Applied Therapeutics
APLT
$68.2M
| $89.6K | ﹤0.01% |
287,998
-13,305
| -4% | -$4.14K |
|
913
ZipRecruiter
ZIP
$421M
| $56.5K | ﹤0.01% |
11,282
-837
| -7% | -$4.19K |
|
914
Vimeo
VMEO
$734M
| $53.9K | ﹤0.01% |
+13,331
| New | +$53.9K |
|
915
BRF SA
BRFS
$5.86B
| $43K | ﹤0.01% |
11,792
+27
| +0.2% | +$99 |
|
|
SBDS
916
Solo Brands, Inc.
SBDS
$18.8M
| $32.1K | ﹤0.01% |
107,025
-4,520
| -4% | -$1.36K |
|
|
DSL
917
DoubleLine Income Solutions Fund
DSL
$1.44B
| – | – |
-70,368
| Closed | -$887K |
|
918
ACI Worldwide
ACIW
$5.19B
| – | – |
-6,942
| Closed | -$380K |
|
|
AGEN
919
Agenus
AGEN
$138M
| – | – |
-23,892
| Closed | -$36K |
|
920
Aldeyra Therapeutics
ALDX
$334M
| – | – |
-69,442
| Closed | -$399K |
|
921
Amphastar Pharmaceuticals
AMPH
$1.37B
| – | – |
-7,764
| Closed | -$225K |
|
922
Biogen
BIIB
$20.6B
| – | – |
-1,891
| Closed | -$259K |
|
923
Brady Corp
BRC
$3.86B
| – | – |
-4,518
| Closed | -$319K |
|
924
Carrier Global
CARR
$55.8B
| – | – |
-3,340
| Closed | -$212K |
|
925
Capitol Federal Financial
CFFN
$846M
| – | – |
-11,425
| Closed | -$64K |
|